Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03834168 · ClinicalTrials.gov registry record · NA
The Diurnal Rhythm in Natriuretic Peptide Levels
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT03834168 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 42 participants.
The verdict
NCT03834168, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of the study to assess the diurnal rhythm in natriuretic peptide levels and its temporal relationship with nocturnal blood pressure in obese and African-American individuals as compared with lean and white individuals.
Interventions
- OTHER standardized Study Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03834168
The ClinicalTrials.gov registry entry for NCT03834168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which standardized Study Diet is the first listed.
NCT03834168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03834168 about?
NCT03834168 is a clinical study titled "The Diurnal Rhythm in Natriuretic Peptide Levels". The purpose of the study to assess the diurnal rhythm in natriuretic peptide levels and its temporal relationship with nocturnal blood pressure in obese and African-American individuals as compared with lean and white individuals.
What is the current status of trial NCT03834168?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2019-04-01. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03834168?
The interventions under investigation include: standardized Study Diet (OTHER).
Who is sponsoring clinical trial NCT03834168?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.